CANNAPHARMARX, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $10.8M
Liabilities Breakdown FY2024
Total Liabilities: $30.6M
Asset Breakdown
Total Assets: $10.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.2K | 0.0% |
| Accounts Receivable | $1.7K | 0.0% |
| Inventory | $996.3K | 9.2% |
| Property, Plant & Equipment | $137.2K | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.7M | 89.5% |
Liabilities Breakdown
Total Liabilities: $30.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.8M | 15.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.9M | 84.4% |